Skip to content

Clinical trials

Hemorrhagic Stroke trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Stroke Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20181
20194
20201
20212
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia4
McGill University2
Abbott Medical Devices1
B-Temia, Inc.1
CSL Behring1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
NoNO Inc.1
Population Health Research Institute1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Stroke13
Ischemic Stroke9
Stroke9
Cardiovascular Diseases3
Atrial Fibrillation2
Brain Diseases2
Brain Infarction2
Brain Ischemia2
Central Nervous System Diseases2
Cerebral Infarction2

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.